DocNexus announced that Jennifer Whipkey, Associate Vice President, Marketing at Menarini Stemline, will be speaking at the DocNexus AI Summit 2026 in Philadelphia on September 18.
Public source
Publisher name
Public post
14 DAYS TO GO. We’re excited to introduce Jennifer Whipkey, Associate Vice President, Marketing at Menarini Stemline, as one of the speakers taking the stage at the DocN…
Company
DocNexus
Unifying global healthcare data into decision-grade intelligence for life sciences teams.
- Industry
- Software Development
- Location
- Seattle, US
- Company size
- 11–50 employees
About DocNexus
DocNexus is an AI-powered commercial real-world data platform that unifies healthcare’s most fragmented data including claims, prescriptions, procedures, referrals, HCP and HCO identities, publications, clinical trials, payments, social signals, and news into decision-ready knowledge graphs for life sciences teams. We help pharmaceutical and biotech companies accelerate research, strengthen competitive intelligence, and make higher-quality strategic decisions with speed and confidence. With coverage spanning 12M+ HCPs and KOLs, 595k+ HCOs, 350M+ patients, and billions of medical, scientific, and digital signals, DocNexus provides a single, comprehensive view of the healthcare ecosystem, continuously refreshed and instantly searchable. Core capabilities include: 🔵KOL and HCP discovery across 36 therapeutic areas using ranking signals from publications, trials, procedures, payments, referrals, and digital influence 🔵Influence and collaboration mapping powered by AI-generated knowledge graphs 🔵Commercial real-world data analytics for opportunity sizing, targeting, and competitive benchmarking 🔵Payer mix, reimbursement, and access insights to support market access strategy 🔵Advanced HCO and IDN search for site selection, procedure density, and health system mapping 🔵AI-powered search across healthcare real-world data that delivers instant, contextual insights to support fast, evidence-based decisions, Life sciences teams use DocNexus to: 🔵Identify KOLs and assemble advisory boards in days instead of weeks 🔵Select high-performing investigators and clinical trial sites with evidence-based precision 🔵Target the right HCOs, IDNs, and referral hubs for commercial strategy 🔵Monitor competitors and emerging scientific leaders in real time 🔵Centralize insights, dashboards, lists, and workflows across medical, commercial, and market access teams
See moreLatest activity
Latest activity from DocNexus
7 signals
Presence & Recognition
DocNexus is hosting an upcoming webinar titled KOL Identification and Segmentation in Breast Cancer on September 10, 2026, at 9:00 AM PT.
Presence & Recognition
DocNexus is attending the Alternative Data Conference New York 2026 at the E2 in the Explorer Hub at Ease Hospitality on September 10, 2026.
Presence & Recognition
DocNexus is hosting an upcoming webinar titled KOL Identification & Segmentation in Breast Cancer on September 10, 2026, at 9:00 AM PT.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Speer Health
Speer Health is presenting at the DocNexus AI Summit 2026 at the Hilton Garden Inn in Philadelphia Center City on September 18, 2026, with Mia Khalid Shibly as the speaker on AI Insights in Medical Affairs.
Presence & Recognition
Veridix, part of Emmes Group
Veridix, part of Emmes Group will be featured in the DPHARM: Disruptive Innovations to Modernize Clinical Trials 2026 event at Grand Ballroom on September 15, 2026, where Jef Benbanaste will explore AI orchestration for clinical trial changes.
Presence & Recognition
Graphnet Health
Graphnet Health announced that Rachel Binks will speak at the HETT 2026 event on Tuesday 29th September at the Digitally Empowered Experience theatre, bringing years of experience delivering out-of-hospital care at Airedale NHS Foundation Trust.
Presence & Recognition
Authenticx
Authenticx CEO Amy Brown is taking the stage at Hub West 2026 alongside Jennifer Macauley and Ryan Napper of Pfizer and Andrea Preuss, MBA, PACS of Keenova Therapeutics to lead two conversations on patient care and care teams.
Presence & Recognition
Vumedi